ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Bacterial infection"

  • 2018 American Transplant Congress

    Assessment of Methenamine Hippurate for the Prevention of Recurrent Urinary Tract Infections in Adult Renal Transplant Recipients: A Single Center, Retrospective Study

    I. Hollyer,1 F. Varias,3 B. Ho,1 M. Ison.1

    1Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL; 2Grinnell College, Grinnell, IA.

    Background: Urinary tract infections (UTI) are common in renal transplant recipients (RTR). Methenamine hippurate is a non-antibiotic drug that inhibits bacterial growth in the bladder…
  • 2018 American Transplant Congress

    Association of Tacrolimus Adherence and Discontinuation with Sepsis Risk among Kidney Transplant Recipients

    J. Donnelly,1 P. MacLennan,1 R. Mannon,1 R. Saran,2 J. Baddley,1 H. Wang,3 G. McGwin, Jr.,1 P. Muntner.1

    1University of Alabama at Birmingham, Birmingham, AL; 2University of Michigan, Ann Arbor, MI; 3University of Texas Health Science Center, Houston, TX.

    OBJECTIVE: The association between post-transplant tacrolimus exposure and sepsis risk is currently unknown. We examined the associations of tacrolimus adherence and discontinuation with sepsis risk…
  • 2018 American Transplant Congress

    Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures

    L. Chen,1 D. Kamiyama,2 L. Francalacci,1 E. Zhu,2 M. Donnelley,2 N. Clayton,2 K. Alman,1 A. De Mattos,1 J. Brown.3

    1Transplant Nephrology, UC Davis Medical Center, Sacramento, CA; 2Pharmacy, UC Davis Medical Center, Sacramento, CA; 3Infectious Diseases, UC Davis Medical Center, Sacramento, CA.

    OBJECTIVES: To evaluate outcomes in renal transplant recipients who received organs from donors with positive blood or urine cultures.METHODS: We performed a retrospective, single-center study…
  • 2017 American Transplant Congress

    Adoptive Immunotherapy with Liver Allograft-Derived Lymphocytes Compensate for the Susceptibility to Post-Liver Transplant Blood Stream Infection Associated with FCGR3A SNP.

    H. Ohdan, M. Ohira, S. Shimizu, Y. Tanaka, H. Tahara, K. Ide, K. Ishiyama, T. Kobayashi.

    Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan

    By studying the single nucleotide polymorphisms (SNPs) of FCGR2A and FCGR3A, genes encoding FcγR, we previously demonstrated the significantly higher incidence of blood stream infections…
  • 2017 American Transplant Congress

    Fosfomycin Tromeltamol (FOS) Is an Effective Alternative in Post Renal Transplant Urinary Tract Infection Prophylaxis Caused by Escherichia coli and Enterococcus faecalis without Increasing Resistance Rate.

    J. Arreola-Guerra,1 J. Alberu,2 L. Morales-Buenrostro,2 E. Maravilla,3 R. Rosado,3 J. Sifuentes.3

    1Nephrology and Transplantation, Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico; 2Transplantation, Instituto Nacional de Nutrición Salvador Zubirán, Mexico, Mexico; 3Medicine, Instituto Nacional de Nutrición Salvador Zubirán, Mexico, Mexico

    Urinary tract infection (UTI) is one of the most important complications in renal transplant recipients (rTR) during the first year after renal transplantation (RT). Antimicrobial…
  • 2017 American Transplant Congress

    Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes.

    S. Brar, Y. Wang, A. Cannitelli, Y. Li, O. Famure, S. Husain, J. Kim.

    Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada

    Background: Bloodstream infections or bacteremia is a serious complication after kidney transplantation. The incidence, risk factors, and outcomes of bacteremia among kidney transplant recipients have…
  • 2017 American Transplant Congress

    Diagnostic Bronchoscopy in Kidney Transplant Recipients with Acute Respiratory Failure: Risk or Value?

    D. Khadzhynov, J. Deissler, F. Halleck, L. Lehner, K. Budde, O. Staeck.

    Nephrology, Charité Universitaetsmedizin, Berlin, Germany

    Introduction:Few data evaluates the differential diagnostic value of bronchoalveolar lavages (FO-BAL) in kidney transplant recipients (KTR) with acute respiratory failure (ARF). We describe the results…
  • 2017 American Transplant Congress

    Ciprofloxacin for Urinary Tract Infection Prophylaxis in Post-Renal Transplant Patients with Ureteral Stent Placement.

    P. Kakadiya, M. Levy, G. Gupta, A. King, S. LeCorchick.

    Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA

    BackgroundUrinary tract infection (UTI) is the most common infection post renal transplant. Sulfamethoxazole-trimethoprim (SMX-TMP) is often the antibiotic drug of choice due to prophylaxis coverage…
  • 2017 American Transplant Congress

    Clostridium difficile Infection in Intestinal Transplant Recipients.

    V. Goldenberg,1 A. Berbel,2 J. Camargo,1 J. Simkins.1

    1Medicine, Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL; 2Medicine, University of Miami Miller School of Medicine, Miami, FL

    Background: Clostridium difficile infection (CDI) data in intestinal transplant (ITx) recipients is lacking. This study was performed to evaluate prevalence, risk factors, treatments and outcomes…
  • 2017 American Transplant Congress

    Clinical Experience with Novel Cephalosporin/Beta-Lactamase Inhibitor Combinations in the Treatment of Multidrug Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplant Recipients.

    P. Nambiar,1 K. Brizendine,1 V. Athans,2 E. Cober.1

    1Infectious Disease, Cleveland Clinic Foundation, Cleveland; 2Pharmacy, Cleveland Clinic Foundation, Cleveland

    Purpose: To review clinical outcomes in organ transplant recipients (OTRs) treated with Ceftazidime/avibactam (C/A) and ceftolozane/tazobactam (C/T) for infections caused by Multidrug resistant Pseudomonas aeruginosa…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences